USPTO serial 90440696
VERICYN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 7, 2023
- Examiner
- STEIN, JAMES W
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with VERICYN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Fort Collins, CO
Fort Collins, CO
FT. COLLINS, CO
Fort Collins, CO
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher D. Olszyk, Jr.
Christopher D. Olszyk, Jr. FOX ROTHSCHILD LLP997 LENOX DRIVE, BLDG. 3LAWRENCEVILLE, NJ 08648-2311UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical ingredients in the nature of antimicrobial substances and preparations for medical purposes for treating, inhibiting and preventing viruses, fungus, mold, bacteria, spores and biofilms; chemical ingredients in the nature of antimicrobial substances sold as a component ingredient of irrigation solutions, namely, medical cleansers for wounds; biostatic antimicrobial preparations for treating, inhibiting and preventing viruses, fungus, mold, bacteria, spores and biofilms; wound antiseptic, medicated cleansers for skin and wounds, and wound irrigation agents, namely, medicated wash and sterilizing preparations; medical cleansers for skin; cleansing solutions for medical use; topical gel for medical and therapeutic treatment of wounds and other skin disorders; antiseptic preparations; antiseptics; where the above product descriptions are expressly limited to products used on humans and sold to and used by medical professionals and institutions for use in negative pressure wound therapy treatment of humans and human wound washes, and excluding products intended for veterinary of other non-human animal use | ACTIVE | Sep 30, 2022 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Armis Biopharma, Inc.
- Other trademarks owned by Armis Biopharma, Inc.
- Other trademarks owned by ARMIS BIOPHARMA, INC.
- Other trademarks owned by Armis Biopharma, Inc.
- Other trademarks in Class 005
- Similar marks named VERICYN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 11, 2025 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 7, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 7, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 3, 2023 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jan 2, 2023 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 6, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 6, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 17, 2022 | IUAF | USE AMENDMENT FILED | — |
| Nov 17, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 17, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 22, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 22, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 2, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 14, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 13, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 13, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 12, 2022 | ALIE | ASSIGNED TO LIE | — |
| Jan 10, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 4, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 4, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 4, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 3, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 2, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 2, 2021 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 5, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 5, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 5, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 26, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 30, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 4, 2021 | NWAP | NEW APPLICATION ENTERED | — |